Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.55
-0.50 (-2.62%)
At close: Jul 31, 2026, 4:00 PM EDT
18.60
+0.05 (0.27%)
After-hours: Jul 31, 2026, 7:48 PM EDT

Legend Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,1391,029627.3285.1117.0168.83
Revenue Growth
56.38%64.02%120.03%143.66%70.00%-8.23%
Gross Profit
626.09620.8392.7140.951.6468.83
Operating Income
-131.63-136.5-309.5-528.1-434.93-406.3
Net Income
-250.27-296.8-177-518.3-446.35-403.58
Earnings Per Share
-1.36-1.62-0.96-2.94-2.80-2.86
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
License
81.1283.8138.435.165065.4
Collaboration
1,058944.8482.58249.866.68-
Other Service
-0.36.260.180.333.42
Revenue (Total)
1,1391,029627.3285.1117.0168.83

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
834.6948.61,1231,3091,026882.4
Total Debt
123.394.649.447.3423.62.5
Net Cash (Debt)
711.38541,0731,2611,002879.89
Net Cash Growth
-24.99%-20.42%-14.92%25.88%13.88%75.17%
Net Cash Per Share
3.854.635.877.166.306.25

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-81.54-100.2-144-393.3-201.28-198.47
Capital Expenditures
--28.6-14.1-20.1-20.93-42.2
Free Cash Flow
-81.54-128.8-158.1-413.4-222.21-240.66
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.98%60.34%62.60%49.42%44.14%100.00%
Operating Margin
-11.56%-13.27%-49.34%-185.23%-371.72%-590.32%
Pretax Margin
-20.78%-27.47%-25.20%-182.46%-380.94%-591.63%
Profit Margin
-20.99%-28.85%-28.22%-181.80%-381.48%-586.38%
FCF Margin
-7.16%-12.52%-25.20%-145.00%-189.91%-349.67%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
24.41150.43----
PS Ratio
3.153.919.5338.3970.43104.45